2024 International Congress » Huntington's Disease

Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease

G. Olmedo Saura, J. Perez Perez, S. Martinez-Horta, A. Puig-Davi, A. Horta-Barba, A. Vazquez-Oliver, A. Campolongo, E. Rivas-Asensio, N. Salvat-Rovira, D. Alcolea, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Assessing Executive Function in HD: Comparing the One Touch Stockings of Cambridge and Zindametrix’s Tower-Z as Components of the HD-CAB

M. Roche, G. Phelan, N. Sinha, A. Patel, A. Mansbach, H. Wilkinson, R. Fuller, J. Stout, S. Lazic, I. Antonijevic, S. Sathe, C. Sampaio (Princeton, USA)

Association between Morbidity and Social Vulnerability in Patients with Huntington Disease

J. Patino, N. Rocha, S. Zadegan, B. Duncan, R. Ramphul, A. Sharrief, E. Furr Stimming (Houston, USA)

Asymmetric Symptomatic Huntington’s Disease in a Patient with Intermediate Range Trinucleotide Repeats

D. Palanisamy, L. Hogan, C. Lim, S. Frank (Boston, USA)

Ataxia and Parkinsonism Related with CAG Expansion Size in a Cohort of Huntington’s Disease in the Brazilian Amazon Region.

M. Della Coletta, C. Camargo, D. Brito, G. Benevides, C. Fantin, D. Cruz, M. Evangelista, F. Carvalho, M. Teles, D. Reis, E. Amaral, H. Teive (Manaus, Brazil)

Baseline lipid traits and the clinical characteristics and disease progression in Huntington’s disease

SR. Zhang, YF. Cheng, HF. Shang (Chengdu, China)

Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)

Correlation Between Low Hemoglobin Levels and Gait Dysfunction in Huntington’s Disease: An Exploratory Study

H. Kaur, A. Margolius (Cleveland, USA)

​​Deciphering the Huntington’s Disease Research Landscape: A Comprehensive Bibliometric and Trend Analysis

S. Khankar, T. Lalotra, A. Subhedar, S. Joshi, S. Mast, A. Bhonsale (Nagpur, India)

Epidemiology of Huntington’s Disease in Latin America: A Systematic Review and Meta-analysis.

A. Medina Escobar, T. Pringsheim, S. Gautreau, J. Rivera-Duarte, G. Amorelli, M. Cornejo-Olivas, M. Rossi (Moncton, Canada)

Exploring Correlations between Mutant Huntingtin, NfL, and MRI in Huntington’s Disease: A Multimodal Analysis

J. Pérez, S. Horta, G. Saura, A. Barba, A. Davi, A. Vázquez, E. Rivas, A. Campolongo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Genetic Migration Dynamics: Unraveling the Influence of Internal Migration on Huntington’s Disease Prevalence in the Amazonas State.

M. Della Coletta, C. Camargo, D. Brito, C. Fantin, G. Benevides, D. Cruz, M. Evangelista, F. Carvalho, M. Teles, D. Reis, E. Amaral, H. Teive (Manaus, Brazil)

Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies

M. Mistry, J. Pace, E. Guivatchian, J. Hinman (Fort Worth, USA)

Indentifying Key Features for Predicting Clinical Status in Huntington’s Disease Patients Using Raw Speech Samples: a Lightweight Machine Learning Approach

T. Le Ludec, C. Le Moine, A-C. Bachoud-Lévi, R. Massart (Creteil, France)

Longitudinal Relationship Between Brain Metabolism and Clinical Changes in Huntington’s Disease

A. Gravier, S. Lavisse, R. Massart, A. Gil-Salcedo, P. Lemercier, O. Barret, V. Gaura, AC. Bachoud-Levi, P. Remy (Créteil, France)

Machine Learning-Driven Exploration of Epigenetic Patterns in Huntington’s Disease: Understanding Histone Modification Dynamics

R. Fajar, E. Syfaruddin, S. Putri (Sleman, Indonesia)

Mapping the Efficacy Landscape: A Network Meta-Analysis of Pharmacological Interventions in Huntington’s Disease

A. Bhonsale, V. Suresh, B. Javed, M. Shamim, T. Dave, V. Ghosh, S. Sen, M. Muneer, D. Dey, M. Jayan, B. Dhakal, S. Vasipalli, R. Jena (Nagpur, India)

Measuring Cortisol Levels in Persons with Huntington’s Disease

A. Clarke, B. Lobb, A. Hiller (Portland, USA)

Modifiable factors associated with Huntington’s disease progression in presymptomatic participants: explained longitudinal machine learning modelling

A. Gil-Salcedo, R. Massart, L. Cleret-de-Langavant, A. Bachoud-Levi (Paris, France)

Muscle mass, body fat mass, and nutrition in patients with Huntington´s Disease

M. Peball, P. Schörghuber, F. Carbone, P. Mahlknecht, F. Krismer, A. Djamshidian, K. Schwarzova, K. Seppi, B. Heim (Innsbruck, Austria)

Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients

R. Singh, V. Sharma (New Delhi, India)

Non-motor symptoms in people with Huntington’s disease: use and validation of the MDS Non-Motor Scale (MDS-NMS)

JM. Valera-Bermejo, N. Martins, O. Makos, J. Badenoch, M. Hartmann, A. Rangel-Cristales, A. Rizos, K. Ray Chaudhuri, D. van Wamelen (London, United Kingdom)

One-year longitudinal decline in spatial location memory in Huntington’s disease

M. Lunven, P. Vanden Enden, Y. Youssov, B. Bapst, G. Morgado, M. Busse, D. Craufurd, A. Rosser, AC. Bachoud-Lévi (Créteil, France)

Patient and Caregiver Experiences with Huntington Disease: Emotions, Challenges, and Unmet Needs in the Patient Journey

A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)

Physical Activity Levels and Demographic Characteristics in Individuals with Huntington’s Disease: Insights from the ENROLL-HD Database in an Argentinian Movement Disorder Center

M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, G. Peker, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

Predicting Clinical Status of Patients with Huntington’s Disease from Raw Speech Samples, a Lightweight Machine Learning Approach

C. Le Moine, R. Massart, A-C. Bachoud-Lévi (Paris, France)

Remote monitoring of upper limb function in Huntington’s disease using a wearable sensor

J. Adams, A. Nunes, R. Mishra, E. Dorsey, A. Vaziri (Rochester, USA)

Serum urea and clinical outcomes in Huntington’s disease

O. Makos, J. Badenoch, M. Hartmann, N. Martin, A. Rangel-Cristales, J. Valera-Bermejo, S. Williams, D. van Wamelen (London, United Kingdom)

Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)

Skin Tau Quantification as a Novel Biomarker in Huntington’s Disease

I. Ruiz Barrio, A. Vazquez Oliver, A. Puig Davi, E. Rivas Asensio, J. Perez Perez, C. Fernandez Vizuete, A. Horta Barba, G. Olmedo Saura, N. Salvat Rovira, E. Vacchi, G. Melli, J. Pagonabarraga Mora, S. Martinez Horta, J. Kulisevsky (Barcelona, Spain)

Somnolence-Related Events Over Time with Valbenazine Treatment for Chorea Associated with Huntington’s Disease

E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, S. Karpuram, D. Thai-Cuarto, G. Liang, D. Haubenberger (Houston, USA)

Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

A. Kumar, P. Mishra (Delhi, India)

Sustained Chorea Improvements with Long-Term, Once-Daily Valbenazine in Adults with Huntington’s Disease

E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)

The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China

YF. Cheng, HF. Shang (Chengdu, China)

The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)

The use of modelling in Huntington’s disease

D. Guest, S. Sathe, C. Sampaio, J. Warner (Princeton, USA)

Time-Restricted Eating in Huntington’s Disease: Review of the Literature and a Proposed Clinical Trial

R. Wells, L. Neilson, A. Mchill, A. Hiller (Portland, USA)

Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data

R. Mehanna, R. Hauser, E. Furr Stimming, L. Citrome, E. Kayson, J. Goldstein, O. Klepitskaya, S. Hinton, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)

Validation of the Korean Version of the Huntington’s Disease Quality of Life Battery for Carers

HJ. Chang, ES. Oh, WT. Yoon, CY. Lee, JY. Lee (Daejeon, Republic of Korea)